1 / 4

Rashida Ferrand rashida.ferrand@lshtm.ac.uk

Getting to the first 95 for children and adolescents: Innovative approaches for pediatric case finding IAS Satellite Session – JSI/AIDSFree Project and Partners July 23, 2018 8 – 10 am. Rashida Ferrand rashida.ferrand@lshtm.ac.uk. Dynamics of the paediatric HIV epidemic.

ping
Download Presentation

Rashida Ferrand rashida.ferrand@lshtm.ac.uk

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Getting to the first 95 for children and adolescents: Innovative approaches for pediatric case findingIAS Satellite Session – JSI/AIDSFree Project and PartnersJuly 23, 2018 8–10 am Rashida Ferrand rashida.ferrand@lshtm.ac.uk

  2. Dynamics of the paediatric HIV epidemic • Dramatic scale up of Prevention of mother-to-child transmission (PMTCT) programmes across Africa • PMTCT coverage variable across the region • “PMTCT” includes HIV testing of HIV-exposed infants & early infant diagnosis (EID); rates remain poor • A third of infected infants have “slow-progressing” disease―median survival 16 years: identified in older childhood UNAIDS Global Report 2017 Wettstein C et al AIDS 2012 Ferrand RA et al AIDS 2009

  3. Barriers to HIV testing in children Kranzer K et al PloS Med 2014; Bandason T et al AIDS Care 2013;

  4. “The first 95” • 95% of individuals with HIV will be diagnosed by 2030 • Testing strategies have targeted infants (PMTCT) and adults • Strategies will need to take into account: • Barriers to testing in children • Physical and social heterogeneity across childhood • Dropping incidence in children

More Related